Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Apr;33(4):369-75.
doi: 10.1111/j.1365-2125.1992.tb04054.x.

Stereoselective disposition of flurbiprofen in normal volunteers

Affiliations

Stereoselective disposition of flurbiprofen in normal volunteers

M P Knadler et al. Br J Clin Pharmacol. 1992 Apr.

Abstract

1. The concentrations of the R- and S-enantiomers of flurbiprofen and its metabolites were measured in plasma and urine following the oral administration of 50 mg racemic flurbiprofen to six normal volunteers. 2. The AUC and half-life of the R-enantiomer were significantly lower than the corresponding S-enantiomer values reflecting the greater clearance of R-flurbiprofen (20.42 +/- 4.71 vs 16.12 +/- 3.60 ml min-1). 3. Ex vivo protein binding studies indicated that the percent unbound of R-flurbiprofen was (not significantly) greater than that of the S-enantiomer (0.055 +/- 0.008 vs 0.049 +/- 0.009) and the corresponding unbound clearances did not show enantioselectivity. 4. Both enantiomers were cleared primarily by metabolism to an acylglucuronide and 4'-hydroxyflurbiprofen. There was significant enantioselectivity (R greater than S) in the formation clearances of these metabolites which remained when unbound metabolite formation clearances were considered. 5. In conclusion, the disposition of the enantiomers of flurbiprofen exhibits enantioselectivity at the level of protein binding and metabolite formation.

PubMed Disclaimer

References

    1. J Pharm Sci. 1989 Sep;78(9):695-715 - PubMed
    1. Clin Pharmacol Ther. 1986 Jan;39(1):15-24 - PubMed
    1. J Pharm Sci. 1988 Aug;77(8):666-9 - PubMed
    1. Eur J Clin Pharmacol. 1989;36(3):283-90 - PubMed
    1. J Pharm Sci. 1985 Jan;74(1):82-4 - PubMed

Publication types

LinkOut - more resources